HK1201150A1 - Scheme for administering n-hydroxy-4-2-[3-(n,n- dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxybenzamide n--4-2-[3-(n,n-)-2-] - Google Patents
Scheme for administering n-hydroxy-4-2-[3-(n,n- dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxybenzamide n--4-2-[3-(n,n-)-2-]Info
- Publication number
- HK1201150A1 HK1201150A1 HK14112851.7A HK14112851A HK1201150A1 HK 1201150 A1 HK1201150 A1 HK 1201150A1 HK 14112851 A HK14112851 A HK 14112851A HK 1201150 A1 HK1201150 A1 HK 1201150A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- ethoxybenzamide
- ylcarbonylamino
- dimethylaminomethyl
- benzofuran
- administering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161573585P | 2011-09-08 | 2011-09-08 | |
| FR1102727 | 2011-09-08 | ||
| PCT/FR2012/052004 WO2013034863A1 (fr) | 2011-09-08 | 2012-09-07 | Schema d'administration du n- hydroxy - 4 - {2- [3- (n, n- dimethylaminomethyl) benzofuran- 2 - ylcarbonylamino] ethoxy} benzamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1201150A1 true HK1201150A1 (en) | 2015-08-28 |
Family
ID=47830027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14112851.7A HK1201150A1 (en) | 2011-09-08 | 2014-12-23 | Scheme for administering n-hydroxy-4-2-[3-(n,n- dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxybenzamide n--4-2-[3-(n,n-)-2-] |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8883199B2 (ru) |
| EP (1) | EP2753322B1 (ru) |
| JP (1) | JP6014142B2 (ru) |
| KR (1) | KR20140073521A (ru) |
| CN (1) | CN103889409A (ru) |
| AR (1) | AR087803A1 (ru) |
| AU (2) | AU2012306122A1 (ru) |
| CA (1) | CA2847011A1 (ru) |
| HK (1) | HK1201150A1 (ru) |
| MX (1) | MX2014002663A (ru) |
| RU (1) | RU2600793C2 (ru) |
| SG (2) | SG11201400120UA (ru) |
| TW (1) | TWI544920B (ru) |
| UA (1) | UA113634C2 (ru) |
| UY (1) | UY34295A (ru) |
| WO (1) | WO2013034863A1 (ru) |
| ZA (1) | ZA201401710B (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05010782A (es) | 2003-04-07 | 2005-12-12 | Axys Pharm Inc | Nuevos hidroxamatos como agentees terapeuticos. |
| JP2010514777A (ja) * | 2006-12-26 | 2010-05-06 | ファーマサイクリックス，インク． | 併用療法においてヒストンデアセチラーゼ阻害剤を使用し、バイオマーカーをモニタする方法 |
| KR101483805B1 (ko) * | 2007-01-30 | 2015-01-16 | 파마시클릭스, 인코포레이티드 | 히스톤 데아세틸라제 억제제에 대한 암 내성을 확인하는 방법 |
| US8603521B2 (en) | 2009-04-17 | 2013-12-10 | Pharmacyclics, Inc. | Formulations of histone deacetylase inhibitor and uses thereof |
| MX365393B (es) | 2011-09-13 | 2019-05-31 | Pharmacyclics Llc | Formulaciones de inhibidor de histona deacetilasa en combinación con bendamustina y usos de las mismas. |
| JP6800750B2 (ja) | 2013-08-02 | 2020-12-16 | ファーマサイクリックス エルエルシー | 固形腫瘍の処置方法 |
| KR101684854B1 (ko) * | 2016-06-13 | 2016-12-09 | 아이오틴 주식회사 | 보호자 알림기능을 이용한 휴대용 스마트약통 및 이를 포함하는 복용시간 알림시스템 |
| CN114146181B (zh) * | 2021-10-29 | 2022-09-09 | 徐诺药业(南京)有限公司 | 含Pan-HDAC和免疫检查点抑制剂的组合及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003221178B2 (en) * | 2002-03-28 | 2006-06-15 | Tanabe Seiyaku Co., Ltd. | Benzofuran derivative |
| AU2003226408B2 (en) * | 2002-04-15 | 2007-06-14 | Sloan-Kettering Institute For Cancer Research | Combination therapy for the treatment of cancer |
| MXPA05010782A (es) * | 2003-04-07 | 2005-12-12 | Axys Pharm Inc | Nuevos hidroxamatos como agentees terapeuticos. |
| BRPI0609939A2 (pt) * | 2005-04-21 | 2010-05-11 | Alza Corp | método para tratar cáncer de ovário avançado com doxorubicina capturada em lipossomas |
-
2012
- 2012-08-28 UY UY0001034295A patent/UY34295A/es not_active Application Discontinuation
- 2012-09-06 US US13/605,116 patent/US8883199B2/en active Active
- 2012-09-06 TW TW101132604A patent/TWI544920B/zh not_active IP Right Cessation
- 2012-09-07 WO PCT/FR2012/052004 patent/WO2013034863A1/fr active Application Filing
- 2012-09-07 AU AU2012306122A patent/AU2012306122A1/en not_active Abandoned
- 2012-09-07 CN CN201280041854.3A patent/CN103889409A/zh active Pending
- 2012-09-07 AR ARP120103299A patent/AR087803A1/es unknown
- 2012-09-07 EP EP12769146.7A patent/EP2753322B1/fr active Active
- 2012-09-07 SG SG11201400120UA patent/SG11201400120UA/en unknown
- 2012-09-07 UA UAA201403500A patent/UA113634C2/uk unknown
- 2012-09-07 JP JP2014529056A patent/JP6014142B2/ja active Active
- 2012-09-07 MX MX2014002663A patent/MX2014002663A/es unknown
- 2012-09-07 RU RU2014113399/15A patent/RU2600793C2/ru not_active IP Right Cessation
- 2012-09-07 KR KR1020147009191A patent/KR20140073521A/ko active Search and Examination
- 2012-09-07 SG SG10201505619QA patent/SG10201505619QA/en unknown
- 2012-09-07 CA CA2847011A patent/CA2847011A1/fr not_active Abandoned
-
2014
- 2014-03-07 ZA ZA2014/01710A patent/ZA201401710B/en unknown
- 2014-10-09 US US14/510,369 patent/US20150024040A1/en not_active Abandoned
- 2014-12-23 HK HK14112851.7A patent/HK1201150A1/xx unknown
-
2016
- 2016-04-22 AU AU2016202594A patent/AU2016202594B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6014142B2 (ja) | 2016-10-25 |
| US20150024040A1 (en) | 2015-01-22 |
| KR20140073521A (ko) | 2014-06-16 |
| US20130064880A1 (en) | 2013-03-14 |
| EP2753322A1 (fr) | 2014-07-16 |
| NZ622112A (en) | 2016-07-29 |
| MX2014002663A (es) | 2014-08-29 |
| AU2016202594B2 (en) | 2017-09-14 |
| WO2013034863A1 (fr) | 2013-03-14 |
| EP2753322B1 (fr) | 2016-08-03 |
| TW201313228A (zh) | 2013-04-01 |
| UY34295A (es) | 2013-04-30 |
| US8883199B2 (en) | 2014-11-11 |
| ZA201401710B (en) | 2015-01-28 |
| UA113634C2 (uk) | 2017-02-27 |
| AU2012306122A1 (en) | 2014-03-13 |
| CN103889409A (zh) | 2014-06-25 |
| JP2014526457A (ja) | 2014-10-06 |
| AR087803A1 (es) | 2014-04-16 |
| SG11201400120UA (en) | 2014-09-26 |
| CA2847011A1 (fr) | 2013-03-14 |
| TWI544920B (zh) | 2016-08-11 |
| RU2014113399A (ru) | 2015-10-20 |
| RU2600793C2 (ru) | 2016-10-27 |
| SG10201505619QA (en) | 2015-08-28 |
| AU2016202594A1 (en) | 2016-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL251744A0 (en) | Anti-il-6 receptor antibody variants, compositions comprising the same and uses thereof | |
| HK1193091A1 (en) | Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3- en-2-ones for therapy 3-(-3-)-88--4--1-[45]-3--2- | |
| ZA201307119B (en) | Double-acylated glp-1 derivatives | |
| HK1181139A1 (zh) | 用於社交摘要的可適配佈局 | |
| EP2762476A4 (en) | 1,2,4-triazine-6-carboxamide derivative | |
| GB201216143D0 (en) | . | |
| EP2699091A4 (en) | 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS | |
| GB201718998D0 (en) | Integrated, extendable anesthesia system | |
| EP2989319A4 (en) | HYDRO-MOTOR MACHINE | |
| HK1201150A1 (en) | Scheme for administering n-hydroxy-4-2-[3-(n,n- dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxybenzamide n--4-2-[3-(n,n-)-2-] | |
| HK1202288A1 (en) | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives 2---35- | |
| HK1198586A1 (zh) | -二氟甲基- -二氫- 噁嗪- -胺衍生物 | |
| GB201203412D0 (en) | . | |
| HK1192757A1 (zh) | 取代的 -芳基- -苯基- -三嗪- -胺 | |
| EP2672024A4 (en) | Operating machine | |
| GB201203063D0 (en) | . | |
| IL227544B (en) | (r)- Leoplomide, a method for its preparation and its medical uses | |
| HK1191942A1 (zh) | 新型六氫環戊二烯並吡咯酮，六氫吡咯並吡咯酮，八氫吡咯並吡啶酮和八氫吡啶酮化合物 | |
| GB201106260D0 (en) | Forced induction for i.c. engines | |
| IL232630A0 (en) | A method for the preparation of 6,2-difluoroacetophenones | |
| GB2510513B (en) | Integrated, extendable anesthesia system | |
| AU2011900916A0 (en) | Garment for ostymates | |
| GB201115337D0 (en) | Seasontickethub.com | |
| GB201110324D0 (en) | Estreettalk.com | |
| GB201105651D0 (en) | S.f.i. |